Topical Janus kinase inhibitor formulations for localized arthritic skin manifestations. Formulated by dermatology-pharma manufacturers, supplied through specialized channels to rheumatology and dermatology offices. Acquired by healthcare providers for external application in psoriatic and reactive arthritis cases.